On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

VPR Brands LP (VPRB) Positioned to Experience Windfall as Thai Hospitals Start Administering Cannabis Oils

  • VPR Brands is set to benefit from the approval of medical marijuana in South Asian markets
  • The Thai marijuana industry is expected to reach $661 million by 2024
  • VPRB announced growth of $1.58 million for Q2 2019, marking a 31 percent increase over last year

VPR Brands LP (OTCQB: VPRB), a technology holding company whose assets include issued U.S. and Chinese patents for atomization-related products, including technology for medical marijuana vaporizers and electronic cigarette products and components, is positioned to benefit as the Southeast Asian medical market could soon start using medical marijuana for the treatment of its patients. This news was announced by Thailand Public Health Minister Anutin Charnvirakul, who is also the deputy prime minister of Thailand (http://cnw.fm/N1bal). This is the first time that Thai state hospitals will be administering cannabis oils to patients since the country passed legislation allowing such treatment.

“This is the outcome of legalizing medical cannabis,” Charnvirakul stated in a press conference. “There is no hidden agenda. We only want to support every patient.” The Government Pharmaceutical Organization (GPO) delivered the initial shipment to the public health ministry to distribute to hospitals for about 4,000 registered patients; additional oils will be distributed in coming weeks.

In December 2018, Thailand became the first Southeast Asian nation to legalize the use of marijuana for medical purposes (http://cnw.fm/0KIbp). Under this law, the Thai government will be regulating the production, processing and sale of medical marijuana products. Prohibition Partners, a marijuana research firm, forecast that the marijuana industry in Thailand could be worth around $661 million by 2024 (http://cnw.fm/Y64ph), and only licensed companies will be granted access to activities related to the new medical marijuana industry.

In addition to its U.S. patents, VPR Brands has Chinese-issued patents for atomization-related products. These patents include technology for medical-marijuana vaporizers and e-cigarette products and components. Since the company is already engaged in dealing with medical-marijuana products in the Chinese arena, the progress of medical marijuana in Thailand will further accelerate the VPR Brands’ expansion plans into the South Asian markets. Industry experts recognized VPR Brands specifically as one such company to be “thrilled that the Asian medical marijuana market could soon open up.”

VPR Brands’ has an extensive line of products that include accessories and vaporizers for cannabidiol (CBD), cannabis extracts and concentrates. The company also develops products for the vaping market, including e-vaporizers and e-liquids, and has alliances with top global brands in the vaping industry. The company’s growth strategy centers on adding more products while increasing production and thereby increasing sales.

VPR Brands CEO Kevin Frija has more than 30 years of valuable marketing and managerial experience. Under his sound leadership, VPR Brands is maneuvering toward the cannabis industry, which has led to an upsurge in sales and profit margins.

Recently, the company announced sales of $1.58 million for the three-month period ended June 30, which marked a 31 percent increase over the same period of 2018 (http://cnw.fm/Q6VIf).

For more information, visit the company’s website at www.VPRBrands.com

NOTE TO INVESTORS: The latest news and updates relating to VPRB are available in the company’s newsroom at http://cnw.fm/VPRB

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Archives

Select A Month

Official NewsWire Relationships

Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722